{"id":"https://openalex.org/W1967069400","doi":"https://doi.org/10.1016/s0009-9236(98)90017-0","title":"Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6*","display_name":"Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6*","alternate_titles":[],"publication_year":1998,"publication_date":"1998-07-01","ids":{"openalex":"https://openalex.org/W1967069400","doi":"https://doi.org/10.1016/s0009-9236(98)90017-0","mag":"1967069400","pmid":"https://pubmed.ncbi.nlm.nih.gov/9695714"},"language":"en","primary_location":{"id":"doi:10.1016/s0009-9236(98)90017-0","doi":"https://doi.org/10.1016/s0009-9236(98)90017-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(98)90017-0","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1967069400"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113733109","display_name":"Adedayo B. Adedoyin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Adedayo Adedoyin","raw_affiliation_strings":["University of Pittsburgh Medical Center, Department of Pharmaceutical Sciences, PA 15213-2582, USA","Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center, Department of Pharmaceutical Sciences, PA 15213-2582, USA","institution_ids":["https://openalex.org/I4210134769"]},{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I4210134769"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022245736","display_name":"Patricia A. Arns","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia A. Arns","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I4210134769"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W.O. Richards","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W.O. Richards","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I4210134769"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108208698","display_name":"Grant R. Wilkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Grant R. Wilkinson","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I4210134769"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA","institution_ids":["https://openalex.org/I200719446"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110054479","display_name":"Robert A. Branch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]},{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert A. Branch","raw_affiliation_strings":["Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Clinical Pharmacology, University of Pittsburgh Medical Center, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I4210134769"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I170201317"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn., USA","institution_ids":["https://openalex.org/I200719446"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5110054479"],"corresponding_institution_ids":["https://openalex.org/I170201317","https://openalex.org/I200719446","https://openalex.org/I4210134769"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":2.6281,"has_fulltext":false,"cited_by_count":108,"citation_normalized_percentile":{"value":0.88692065,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"64","issue":"1","first_page":"8","last_page":"17"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liver-disease","display_name":"liver disease","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cyp2c19","display_name":"CYP2C19","score":0.9509999752044678},{"id":"https://openalex.org/keywords/cyp2d6","display_name":"CYP2D6","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.8259999752044678},{"id":"https://openalex.org/keywords/mephenytoin","display_name":"mephenytoin","score":0.9150000214576721},{"id":"https://openalex.org/keywords/debrisoquin","display_name":"debrisoquin","score":0.9490000009536743},{"id":"https://openalex.org/keywords/enzyme-selectivity","display_name":"enzyme selectivity","score":0.7160000205039978},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.625},{"id":"https://openalex.org/keywords/hepatic-clearance","display_name":"hepatic clearance","score":0.4390000104904175}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.55678790807724},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.5367525815963745},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.5229642987251282},{"id":"https://openalex.org/C3020359197","wikidata":"https://www.wikidata.org/wiki/Q1359801","display_name":"Liver enzyme","level":2,"score":0.4388037621974945},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4238336384296417},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.32901349663734436},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31785106658935547},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24303120374679565}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D001189","descriptor_name":"Aryl Hydrocarbon Hydroxylases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003647","descriptor_name":"Debrisoquin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003647","descriptor_name":"Debrisoquin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003647","descriptor_name":"Debrisoquin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D003647","descriptor_name":"Debrisoquin","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006899","descriptor_name":"Mixed Function Oxygenases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008617","descriptor_name":"Mephenytoin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D008617","descriptor_name":"Mephenytoin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008617","descriptor_name":"Mephenytoin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008617","descriptor_name":"Mephenytoin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D008617","descriptor_name":"Mephenytoin","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D008657","descriptor_name":"Metabolic Clearance Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013237","descriptor_name":"Stereoisomerism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013565","descriptor_name":"Sympatholytics","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013565","descriptor_name":"Sympatholytics","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013565","descriptor_name":"Sympatholytics","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D013565","descriptor_name":"Sympatholytics","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D019389","descriptor_name":"Cytochrome P-450 CYP2D6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0009-9236(98)90017-0","doi":"https://doi.org/10.1016/s0009-9236(98)90017-0","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0009-9236(98)90017-0","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:9695714","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9695714","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G7982882065","display_name":"DETERMINANTS  OF INDIVIDUAL RESPONSIVENESS TO DRUGS","funder_award_id":"P01GM031304","funder_id":"https://openalex.org/F4320337354","funder_display_name":"National Institute of General Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320337354","display_name":"National Institute of General Medical Sciences","ror":"https://ror.org/04q48ey07"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1829225133","https://openalex.org/W1833106351","https://openalex.org/W1932158148","https://openalex.org/W1948441043","https://openalex.org/W1973755332","https://openalex.org/W1985259581","https://openalex.org/W1985904589","https://openalex.org/W1997586764","https://openalex.org/W1999715469","https://openalex.org/W2006998778","https://openalex.org/W2014856914","https://openalex.org/W2017109601","https://openalex.org/W2022161410","https://openalex.org/W2022820704","https://openalex.org/W2023437376","https://openalex.org/W2026991287","https://openalex.org/W2027138973","https://openalex.org/W2027613749","https://openalex.org/W2029885817","https://openalex.org/W2031143163","https://openalex.org/W2045066352","https://openalex.org/W2050286196","https://openalex.org/W2057467439","https://openalex.org/W2060123467","https://openalex.org/W2067525361","https://openalex.org/W2069157036","https://openalex.org/W2069464478","https://openalex.org/W2071130404","https://openalex.org/W2071332031","https://openalex.org/W2075870841","https://openalex.org/W2082425802","https://openalex.org/W2084256384","https://openalex.org/W2084686194","https://openalex.org/W2087671399","https://openalex.org/W2090134988","https://openalex.org/W2107967600","https://openalex.org/W2114800723","https://openalex.org/W2115717824","https://openalex.org/W2121839631","https://openalex.org/W2126463687","https://openalex.org/W2139156463","https://openalex.org/W2236580798","https://openalex.org/W2337323504","https://openalex.org/W2397594933","https://openalex.org/W2399510505","https://openalex.org/W2401549588","https://openalex.org/W2401633376","https://openalex.org/W2407008065","https://openalex.org/W2408646082","https://openalex.org/W2412742343","https://openalex.org/W2807538053","https://openalex.org/W4317563882"],"related_works":["https://openalex.org/W2155690985","https://openalex.org/W2270708832","https://openalex.org/W2070590665","https://openalex.org/W2083292852","https://openalex.org/W206457797","https://openalex.org/W1994150258","https://openalex.org/W2159248641","https://openalex.org/W2005497721","https://openalex.org/W1503850052","https://openalex.org/W73001605"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"OBJECTIVES:":[2],"Drug":[3],"metabolism":[4,51,243],"is":[5,27],"influenced":[6,37],"by":[7,38],"liver":[8,17,44,86,134,203,230,264],"disease":[9,87,160,204,231],"because":[10],"of":[11,32,43,52,68,80,94,103,126,155,178,190,202,207,229,237,244,255,263],"the":[12,16,23,39,153,175,188,200,227,238,245,250,261],"central":[13],"role":[14],"that":[15,219],"plays":[18],"in":[19,22,50,77,114,137,141,174,199,223,226,242,260],"metabolic":[20],"activities":[21,31,67,206],"body.":[24],"However,":[25],"it":[26],"still":[28],"unclear":[29],"how":[30],"specific":[33,53,208,257],"drug-metabolizing":[34,258],"enzymes":[35],"are":[36],"presence":[40,228,262],"and":[41,73,91,108,116],"severity":[42,154],"disease.":[45,169,265],"As":[46],"a":[47,78,92,138],"consequence,":[48],"alteration":[49],"drugs":[54],"cannot":[55],"be":[56,233],"easily":[57],"predicted":[58],"or":[59,84,192],"appropriate":[60],"dosage":[61,225],"adjustment":[62],"recommendations":[63,220],"made.":[64],"METHODS:":[65],"The":[66,101,124,247],"cytochromes":[69],"P450":[70],"(CYP)":[71],"2C19":[72],"2D6":[74],"were":[75,112,172],"investigated":[76],"group":[79,93],"patients":[81,132,146,157,166],"with":[82,133,158,167],"mild":[83,168],"moderate":[85,159],"(n":[88,98],"=":[89,99],"18)":[90],"healthy":[95],"control":[96],"subjects":[97],"10).":[100],"disposition":[102,189],"racemic":[104],"mephenytoin":[105],"for":[106,110,144,221,252],"CYP2C19":[107,211],"debrisoquin":[109],"CYP2D6":[111],"characterized":[113],"plasma":[115,142],"urine":[117],"samples":[118],"collected":[119],"over":[120],"192":[121],"hours.":[122],"RESULTS:":[123],"elimination":[125],"S-mephenytoin":[127],"was":[128,150,184],"severely":[129,164],"reduced":[130],"among":[131],"disease,":[135,156],"resulting":[136],"79%":[139],"decrease":[140],"clearance":[143],"all":[145],"combined.":[147],"This":[148],"reduction":[149],"related":[151],"to":[152],"being":[161,212],"affected":[162],"more":[163,213],"than":[165,215],"Similar":[170],"differences":[171],"observed":[173],"urinary":[176],"excretion":[177],"4'-hydroxymephenytoin":[179],"metabolite.":[180],"By":[181],"contrast,":[182],"there":[183],"no":[185],"effect":[186,201],"on":[187,205,235],"R-mephenytoin":[191],"debrisoquin.":[193],"CONCLUSION:":[194],"These":[195],"results":[196,248],"show":[197],"selectivity":[198],"metabolizing":[209],"enzymes,":[210],"sensitive":[214],"CYP2D6.":[216],"They":[217],"suggest":[218],"modification":[222],"drug":[224],"should":[232],"based":[234],"knowledge":[236],"particular":[239],"enzyme":[240,259],"involved":[241],"drug.":[246],"emphasize":[249],"need":[251],"further":[253],"studies":[254],"each":[256]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1967069400","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
